0000950170-23-045084.txt : 20230829
0000950170-23-045084.hdr.sgml : 20230829
20230829163226
ACCESSION NUMBER: 0000950170-23-045084
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230828
FILED AS OF DATE: 20230829
DATE AS OF CHANGE: 20230829
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Werner Michelle C
CENTRAL INDEX KEY: 0001991154
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40657
FILM NUMBER: 231222353
MAIL ADDRESS:
STREET 1: C/O OMEGA THERAPEUTICS, INC.
STREET 2: 20 ACORN PARK D
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Omega Therapeutics, Inc.
CENTRAL INDEX KEY: 0001850838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 140 FIRST STREET, SUITE 501
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
BUSINESS PHONE: (617) 949-4360
MAIL ADDRESS:
STREET 1: 140 FIRST STREET, SUITE 501
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
4
1
ownership.xml
4
X0508
4
2023-08-28
0001850838
Omega Therapeutics, Inc.
OMGA
0001991154
Werner Michelle C
C/O OMEGA THERAPEUTICS, INC.
140 FIRST STREET, SUITE 501
CAMBRIDGE
MA
02141
true
false
false
false
false
Stock Option (Right to Buy)
3.62
2023-08-28
4
A
false
36713
0.00
A
2033-08-27
Common Stock
36713
36713
D
The option vests and becomes exercisable in thirty-six substantially equal monthly installments following the date of grant, such that the option shall be fully vested and exercisable on the third anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date.
/s/ Barbara Chan as Attorney-in-Fact for Michelle C. Werner
2023-08-29